Results 121 to 130 of about 33,593 (191)

Activity of aztreonam-avibactam, cefiderocol, and cefepime-taniborbactam against a global collection of genetically characterized metallo-β-lactamase-producing Enterobacterales. [PDF]

Antimicrob Agents Chemother
Castanheira M, Kimbrough JH, Morgan GM, Karr M, Sader HS.   +4 more
europepmc   +1 more source

Molecular characterization and resistance mechanisms of ertapenem-non-susceptible carbapenem-resistant <i>Klebsiella pneumoniae</i> co-harboring ESBLs or AmpC enzymes with porin loss or efflux pump overexpression. [PDF]

J Bacteriol
Su Y, Zou G, Huang X, Bi J, Meng L, Zhao W, Li T.   +6 more
europepmc   +1 more source

<i>In vitro</i> activity of cefepime/zidebactam against <i>Klebsiella pneumoniae</i> carrying <i>bla</i> _KPC variants conferring resistance to ceftazidime/avibactam. [PDF]

JAC Antimicrob Resist
Tascini C, Marshall SH, Bonomo RA, Gaibani P.   +3 more
europepmc   +1 more source

In Vitro and In Silico Analysis of Differential Antibacterial Activity of Pomegranate Polyphenols Against Gram-Positive and Gram-Negative Bacteria. [PDF]

Antibiotics (Basel)
Suručić R, Travar M, Kundaković Vasović T, Radović Selgrad J, Suručić L, Momčilović M, Stojiljković MP, Škrbić R.   +7 more
europepmc   +1 more source

ESBL-Producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> Exhibit Divergent Paths During In-Human Evolution Towards Carbapenem Resistance. [PDF]

Microorganisms
Kalu MC, Acharya A, Jorth P, Wong-Beringer A.   +3 more
europepmc   +1 more source

Phenotypic profile and molecular mechanism of resistance in carbapenemase-producing Enterobacterales and <i>Pseudomonas aeruginosa</i> isolates from Brazilian hospitals: implications for the introduction of imipenem-relebactam. [PDF]

Front Microbiol
Kurtz P, Del Peloso PF, Pribul BR, Albuquerque AM, Antunes BBP, Ramos GV, Bozza FA.   +6 more
europepmc   +1 more source

Augmentation of antibacterial activity of ciprofloxacin by bisabololoxide A encapsulated in polymeric nanoparticles against uropathogenic Escherichia coli. [PDF]

BMC Biotechnol
Bazgosha M, Saberi GA, Hormozi M, Shirangi K, Shaghaghi Bahri F, Zahmatkesh H, Rasti B, Najafi F, Ranji N, Nikpassand M, Shahriarinour M.   +10 more
europepmc   +1 more source

Harnessing biological insights to accelerate drug discovery against ESKAPE pathogens. [PDF]

RSC Med Chem
Palmo T, Jamwal V, Kumari D, Singh K.
europepmc   +1 more source

Carbapenem resistance in a <i>Klebsiella quasipneumoniae</i> isolate resulting from production of CTX-M-33 and OmpK36 porin deficiency. [PDF]

Antimicrob Agents Chemother
Findlay J, Nordmann P, Jayol A, Seth-Smith HMB, Egli A, Poirel L.   +5 more
europepmc   +1 more source

Molecular Insights into Carbapenem Resistance in <i>Klebsiella pneumoniae</i>: From Mobile Genetic Elements to Precision Diagnostics and Infection Control. [PDF]

Int J Mol Sci
Elbehiry A, Marzouk E, Abalkhail A.
europepmc   +1 more source